- Home
- CDNA vs TRS Comparison
CDNA vs TRS Comparison
Compare CDNA & TRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDNA
- TRS
- Stock Information
- Founded
- CDNA 1998
- TRS 1986
- Country
- CDNA United States
- TRS United States
- Employees
- CDNA N/A
- TRS N/A
- Industry
- CDNA Medical Specialities
- TRS Industrial Specialties
- Sector
- CDNA Health Care
- TRS Industrials
- Exchange
- CDNA Nasdaq
- TRS Nasdaq
- Market Cap
- CDNA 1.0B
- TRS 1.0B
- IPO Year
- CDNA 2014
- TRS 2007
- Fundamental
- Price
- CDNA $19.21
- TRS $28.43
- Analyst Decision
- CDNA Buy
- TRS Strong Buy
- Analyst Count
- CDNA 6
- TRS 1
- Target Price
- CDNA $30.33
- TRS $40.00
- AVG Volume (30 Days)
- CDNA 989.3K
- TRS 423.2K
- Earning Date
- CDNA 07-30-2025
- TRS 07-29-2025
- Dividend Yield
- CDNA N/A
- TRS 0.56%
- EPS Growth
- CDNA N/A
- TRS N/A
- EPS
- CDNA 1.07
- TRS 0.77
- Revenue
- CDNA $346,421,000.00
- TRS $939,580,000.00
- Revenue This Year
- CDNA $13.31
- TRS $6.37
- Revenue Next Year
- CDNA $15.46
- TRS $5.49
- P/E Ratio
- CDNA $17.90
- TRS $36.88
- Revenue Growth
- CDNA 25.92
- TRS 3.80
- 52 Week Low
- CDNA $14.09
- TRS $19.33
- 52 Week High
- CDNA $34.84
- TRS $28.77
- Technical
- Relative Strength Index (RSI)
- CDNA 57.48
- TRS 68.18
- Support Level
- CDNA $18.64
- TRS $27.53
- Resistance Level
- CDNA $19.44
- TRS $28.07
- Average True Range (ATR)
- CDNA 0.75
- TRS 0.73
- MACD
- CDNA -0.05
- TRS 0.03
- Stochastic Oscillator
- CDNA 46.86
- TRS 86.32
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
About TRS TriMas Corporation
TriMas Corp designs, develops and manufactures a diverse set of products primarily for the consumer products, aerospace & defense, and industrial markets . The company operates through three segments namely: The packaging segment manufactures and distributes closure and dispensing systems. The aerospace segment supplies blind bolts, fasteners, rivets, and other products for the aerospace industry. The specialty product segment manufactures and distributes steel cylinders, wellhead engines, compression systems, industrial sealing, and fasteners.